Brief: Brain AG And Cyplus Develop Disruptive Technologies For Biological Processing Of Precious Metal Ores
June 20 (Reuters) - BRAIN Biotechnology Research and
Information Network AG BNNn.DE :
* BRAIN AG AND CYPLUS GMBH DEVELOP DISRUPTIVE TECHNOLOGIES
FOR
BIOLOGICAL PROCESSING OF PRECIOUS METAL ORES
* MARKET LAUNCH OF INITIAL PRODUCTS EXPECTED IN COURSE OF
2019
Source text for Eikon: ID:nEQ5RqffDa
Further company coverage: BNNn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on BRAIN Biotech AG
See all newsBrief: BRAIN Biotech 9M EBITDA EUR -1.6 Million
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt